Squarepoint’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,386
| Closed | -$14.1K | – | 3021 |
|
2024
Q4 | $14.1K | Buy |
+1,386
| New | +$14.1K | ﹤0.01% | 2722 |
|
2023
Q4 | – | Sell |
-2,277
| Closed | -$45.8K | – | 2748 |
|
2023
Q3 | $45.8K | Buy |
+2,277
| New | +$45.8K | ﹤0.01% | 2335 |
|
2023
Q2 | – | Sell |
-837
| Closed | -$48.8K | – | 2629 |
|
2023
Q1 | $48.8K | Sell |
837
-2,649
| -76% | -$155K | ﹤0.01% | 2118 |
|
2022
Q4 | $178K | Buy |
+3,486
| New | +$178K | ﹤0.01% | 1924 |
|
2022
Q1 | – | Sell |
-8,285
| Closed | -$799K | – | 2552 |
|
2021
Q4 | $799K | Buy |
+8,285
| New | +$799K | ﹤0.01% | 1339 |
|
2021
Q3 | – | Sell |
-2,294
| Closed | -$355K | – | 2507 |
|
2021
Q2 | $355K | Buy |
+2,294
| New | +$355K | ﹤0.01% | 1846 |
|
2021
Q1 | – | Sell |
-5,337
| Closed | -$1.24M | – | 2804 |
|
2020
Q4 | $1.24M | Sell |
5,337
-5,231
| -49% | -$1.21M | 0.01% | 952 |
|
2020
Q3 | $2.31M | Buy |
10,568
+7,811
| +283% | +$1.71M | 0.03% | 576 |
|
2020
Q2 | $783K | Sell |
2,757
-1,059
| -28% | -$301K | 0.01% | 1067 |
|
2020
Q1 | $1.1M | Buy |
3,816
+2,257
| +145% | +$651K | 0.03% | 682 |
|
2019
Q4 | $448K | Buy |
+1,559
| New | +$448K | ﹤0.01% | 1785 |
|
2019
Q3 | – | Sell |
-1,304
| Closed | -$117K | – | 2407 |
|
2019
Q2 | $117K | Buy |
+1,304
| New | +$117K | ﹤0.01% | 2131 |
|
2019
Q1 | – | Sell |
-3,521
| Closed | -$495K | – | 2245 |
|
2018
Q4 | $495K | Buy |
3,521
+48
| +1% | +$6.75K | 0.01% | 1234 |
|
2018
Q3 | $887K | Buy |
3,473
+2,493
| +254% | +$637K | 0.01% | 1045 |
|
2018
Q2 | $250K | Buy |
+980
| New | +$250K | ﹤0.01% | 1458 |
|
2018
Q1 | – | Sell |
-860
| Closed | -$124K | – | 1920 |
|
2017
Q4 | $124K | Buy |
+860
| New | +$124K | ﹤0.01% | 1906 |
|
2017
Q1 | – | Sell |
-1,140
| Closed | -$161K | – | 1717 |
|
2016
Q4 | $161K | Buy |
+1,140
| New | +$161K | 0.01% | 1515 |
|